All of my email lists are abuzz over the ruling in Tafas v. Dudas, which Patently-O covers much better than I ever could:
In a twenty-six page opinion, District Court Judge Cacheris has granted GSK’s and Tafas’s Motions for Summary Judgment — finding the PTO’s proposed limitations to the number of continuation applications and claims per patent to be improper extensions of PTO authority:
“Because the USPTO’s rulemaking authority under 35 U.S.C. § 2b2 does not extend to substantive rules, and because the Final Rules are substantive in nature, the Court finds that the Final Rules are void as ‘otherwise not in accordance with law’ and ‘in excess of statutory jurisdiction [and] authority.’ 5 U.S.C. § 7062.”
The documents:
Filed under: 2008 Patent Cases, Patents
